产品标题 产品货号 产品规格 厂家
Human Colon: right; Adenocarcinoma of colon, metastatic from ORIGENE TECHNOLOGIESCS7098505x5umORIGENE TECHNOLOGIES
PPARD - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4147351 kitORIGENE TECHNOLOGIES
Ppard - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5136741 kitORIGENE TECHNOLOGIES
PPARD Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31473510 ugORIGENE TECHNOLOGIES
Human EG-VEGF ELISA Kit from ORIGENE TECHNOLOGIESEA1003968x12 divisible stripORIGENE TECHNOLOGIES
Human EH-domain containing 2 (EHD2) from ORIGENE TECHNOLOGIESTP30484820 ugORIGENE TECHNOLOGIES
Human EH-domain containing 1 (EHD1) from ORIGENE TECHNOLOGIESTP31115820 ugORIGENE TECHNOLOGIES
Human EH-domain containing 3 (EHD3) from ORIGENE TECHNOLOGIESTP31416820 ugORIGENE TECHNOLOGIES
FKBP1B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4006671 kitORIGENE TECHNOLOGIES
Fkbp1b - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5059891 kitORIGENE TECHNOLOGIES
FKBP1B Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30066710 ugORIGENE TECHNOLOGIES
Human rhophilin, Rho GTPase binding protein 1 (RHPN1) from ORIGENE TECHNOLOGIESTP30664520 ugORIGENE TECHNOLOGIES
Human rhophilin, Rho GTPase binding protein 2 (RHPN2) from ORIGENE TECHNOLOGIESTP30547920 ugORIGENE TECHNOLOGIES
Human rho/rac guanine nucleotide exchange factor (GEF) 2 (ARHGEF2) from ORIGENE TECHNOLOGIESTP30454620 ugORIGENE TECHNOLOGIES
Human Rho-related BTB domain containing 1 (RHOBTB1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30631020 ugORIGENE TECHNOLOGIES
Human rhotekin (RTKN), transcript variant 1 from ORIGENE TECHNOLOGIESTP31881020 ugORIGENE TECHNOLOGIES
Human rhotekin (RTKN), transcript variant 2 from ORIGENE TECHNOLOGIESTP30451720 ugORIGENE TECHNOLOGIES
Human activin A receptor, type I (ACVR1), transcript variant 1 from ORIGENE TECHNOLOGIESTP30748620 ugORIGENE TECHNOLOGIES
Human activin A receptor, type I (ACVR1), transcript variant 2 from ORIGENE TECHNOLOGIESTP32587720 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IC (ACVR1C), transcript variant 4 from ORIGENE TECHNOLOGIESTP32549420 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IIA (ACVR2A) from ORIGENE TECHNOLOGIESTP72068710 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IIA (ACVR2A) from ORIGENE TECHNOLOGIESTP72105910 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IIB (ACVR2B) from ORIGENE TECHNOLOGIESTP72082610 ugORIGENE TECHNOLOGIES
Human activin A receptor type II-like 1 (ACVRL1), transcript variant 2 from ORIGENE TECHNOLOGIESTP31338920 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IIB (ACVR2B) from ORIGENE TECHNOLOGIESTP31281620 ugORIGENE TECHNOLOGIES
Human activin A receptor, type IIB (ACVR2B) from ORIGENE TECHNOLOGIESTP72103150 ugORIGENE TECHNOLOGIES
Human furin (paired basic amino acid cleaving enzyme) (FURIN). from ORIGENE TECHNOLOGIESTP72311910 ugORIGENE TECHNOLOGIES
Human furin (paired basic amino acid cleaving enzyme) (FURIN) from ORIGENE TECHNOLOGIESTP30427920 ugORIGENE TECHNOLOGIES
Human FUS interacting protein (serine/arginine-rich) 1 (FUSIP1), transcript variant 1 from ORIGENE TECHNOLOGIESTP32175920 ugORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of kidney, renal cell, papillary from ORIGENE TECHNOLOGIESCS7060455x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS7029455x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS7050315x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS7050325x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS7069795x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS5101135x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS5171695x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, papillary transitional cell from ORIGENE TECHNOLOGIESCS5230565x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7021685x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7059495x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7059855x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7059865x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7059875x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7080885x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7080895x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7080905x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7080915x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7080925x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7090745x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7104085x5umORIGENE TECHNOLOGIES
Human Renal pelvis; Carcinoma of renal pelvis, transitional cell from ORIGENE TECHNOLOGIESCS7170015x5umORIGENE TECHNOLOGIES
 |< < 4762 4763 4764 4765 4766 4767 4768 4769 4770 > >| 第 4769/6274 页